Author

Francisco Mesonero 1

1 Hospital Ramón y Cajal, Madrid, Spain

Is the switch to a second thiopurine a safe strategy in elderly patients with inflammatory bowel disease? A multicentre cohort study of the ENEIDA registry

Margalida Calafat Sard, Miriam Mañosa, Elena Ricart, Sandra Marín Pedrosa, Marta Calvo, Francisco Rodriguez-Moranta, Carlos Taxonera Samso, Pilar Nos Mateu, Francisco Mesonero, Mariló Martin-Arranz, Miguel Mínguez, Javier Gisbert, Santiago García-López, Ruth De Francisco Garcia, Fernando Gomollón Garcia, Xavier Calvet, Esth

IDIOPATHIC ACUTE PANCREATITIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A MULTICENTRIC COHORT STUDY

Ana García García de Paredes, Carlos Rodríguez-Escaja, Marisa Iborra, Alicia Algaba, Jose Ignacio Cameo, Luisa de la Peña, Fernando Gomollón, Manuel Van Domselaar, Reyes Busta, Enrique Rodríguez de Santiago, Andres Castaño García, Adolfo del Val, Fernando Bermejo, Ana Gutiérrez, Jordi Guardiola, Francisco Mesonero, Sabino

METHOTREXATE AFTER ANTI-TNF-α FAILURE IN CROHN'S DISEASE: A RETROSPECTIVE SERIES FROM THE ENEIDA REGISTRY. TEACHING AN OLD DOG NEW TRICKS?

Francisco Mesonero

EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB FOR THE INDUCTION OF REMISSION IN INFLAMMATORY BOWEL DISEASE PATIENTS

Maria Chaparro Sanchez, M Sierra-Ausin, Francisco Mesonero, Ana Belen Beltran Niclos, Nuria Maroto Arce, Ruth De Francisco Garcia, Miguel Mínguez, Y González-Lama, Manuel Barreiro de Acosta, IGNACIO MARIN, Valle García, David Busquets Casals, Alfredo J. Lucendo, Santiago García, Fernando Bermejo, Ramón Pajares Villarroya, B

METHOTREXATE AFTER ANTI-TNF-α FAILURE IN CROHN'S DISEASE: A RETROSPECTIVE SERIES FROM THE ENEIDA REGISTRY. TEACHING AN OLD DOG NEW TRICKS?

Francisco Mesonero, Jesus Castro Poceiro, Elena Ricart, Jose Manuel Benitez, Blau Camps Aler, Jordi Guardiola, Marisa Iborra, Alicia López-García, Paola Francesca Torres Rodríguez, María Esteve, Joan Tosca, Federico Bertoletti, Pedro Almela, Xavier Calvet, Maria Isabel Vera, Luis Bujanda, Fernando Gomollón Garcia, Cristina

Spacing the administration interval of anti-TNF agents: a valid strategy for patients with inflammatory bowel disease?

Paola Francesca Torres Rodríguez, Laura Núñez, Ariadna Aguilar, Miriam Mañosa, Francisco Mesonero, Fiorella Cañete, Margalida Calafat, Cristina Fernandez, EDUARD CABRE, Antonio López-San Román, Eugeni Domenech Morral

USE OF IMMUNOSUPRESSANTS AND BIOLOGICAL AGENTS IN IBD PATIENTS WITH PAST HISTORY OF CANCER

Miriam Mañosa Ciria, Alba Juan Juan, Jordi Guardiola Capon, Ignacio Alfaro Perez, Miguel Mínguez, Benito Velayos Jiménez, Jose Manuel Benítez Cantero, Francisco Mesonero, Maria Chaparro Sanchez, Beatriz Sicília Aladrén, Yamile Zabana Abdo, Albert Villoria, Rufo Lorente Poyatos, Maria Pilar Martinez Montiel, Luis Bujanda Ferná

Item 1 - 7 / 7
1